These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31694529)

  • 1. Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans.
    Dbouk NH; Covington MB; Nguyen K; Chandrasekaran S
    BMC Microbiol; 2019 Nov; 19(1):243. PubMed ID: 31694529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro.
    Peng CA; Gaertner AAE; Henriquez SA; Fang D; Colon-Reyes RJ; Brumaghim JL; Kozubowski L
    PLoS One; 2018; 13(12):e0208471. PubMed ID: 30532246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony and Single Cell Level Analysis of the Heterogeneous Response of
    Altamirano S; Simmons C; Kozubowski L
    Front Cell Infect Microbiol; 2018; 8():203. PubMed ID: 29971221
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B.
    Carlson T; Lupinacci E; Moseley K; Chandrasekaran S
    FEMS Microbiol Lett; 2021 May; 368(7):. PubMed ID: 33877319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation.
    Xu Y; Wang Y; Yan L; Liang RM; Dai BD; Tang RJ; Gao PH; Jiang YY
    J Proteome Res; 2009 Nov; 8(11):5296-304. PubMed ID: 19754040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress.
    Chang YC; Khanal Lamichhane A; Kwon-Chung KJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A.
    Florio AR; Ferrari S; De Carolis E; Torelli R; Fadda G; Sanguinetti M; Sanglard D; Posteraro B
    BMC Microbiol; 2011 May; 11():97. PubMed ID: 21569340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.
    Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
    FEMS Yeast Res; 2012 Nov; 12(7):748-54. PubMed ID: 22731401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5.
    Zhou J; Li J; Cheong I; Liu NN; Wang H
    Bioorg Med Chem; 2021 Aug; 44():116293. PubMed ID: 34243044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological Differences in Cryptococcus neoformans Strains
    Grossman NT; Casadevall A
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031206
    [No Abstract]   [Full Text] [Related]  

  • 11. Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells.
    Thangamani S; Eldesouky HE; Mohammad H; Pascuzzi PE; Avramova L; Hazbun TR; Seleem MN
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3002-3010. PubMed ID: 27712973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
    Paul S; Doering TL; Moye-Rowley WS
    Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
    Li LP; Liu W; Liu H; Zhu F; Zhang DZ; Shen H; Xu Z; Qi YP; Zhang SQ; Chen SM; He LJ; Cao XJ; Huang X; Zhang JD; Yan L; An MM; Jiang YY
    PLoS One; 2015; 10(5):e0126393. PubMed ID: 25992630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Ghaffar M; Orr C; Webb G
    PLoS One; 2019; 14(12):e0225701. PubMed ID: 31800598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
    Sionov E; Chang YC; Garraffo HM; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2804-15. PubMed ID: 19414582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coregulation of extracellular vesicle production and fluconazole susceptibility in
    Rizzo J; Trottier A; Moyrand F; Coppée JY; Maufrais C; Zimbres ACG; Dang TTV; Alanio A; Desnos-Ollivier M; Mouyna I; Péhau-Arnaude G; Commere PH; Novault S; Ene IV; Nimrichter L; Rodrigues ML; Janbon G
    mBio; 2023 Aug; 14(4):e0087023. PubMed ID: 37310732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner.
    Semighini CP; Averette AF; Perfect JR; Heitman J
    PLoS Pathog; 2011 Nov; 7(11):e1002364. PubMed ID: 22114551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.
    Sionov E; Lee H; Chang YC; Kwon-Chung KJ
    PLoS Pathog; 2010 Apr; 6(4):e1000848. PubMed ID: 20368972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB; Sujatha S; Parija SC
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex.
    Sá NP; Lima CM; Lino CI; Barbeira PJS; Baltazar LM; Santos DA; Oliveira RB; Mylonakis E; Fuchs BB; Johann S
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.